Gardasil Administration
NCT03123419 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-03-07
Summary
The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.
Conditions
- Vaccine Administration Rates
Interventions
- BEHAVIORAL
-
Appointment reminders
The purpose of the Gardasil study is to increase the rates of Gardasil vaccination in the Maternal Fetal Care Center. This will be done by reminding patients via text to come for their follow up vaccine appointments.
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Sarah Hostetter, MD · St. Louis University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 9 Years
- Max Age
- 26 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2019-03-01
- Completion
- 2019-04-01
Countries
- United States
Study Locations
More Related Trials
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial
NCT04688476 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832 ·Status: COMPLETED ·Phase: NA
-
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
NCT01245764 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9
NCT03431246 ·Status: COMPLETED ·Phase: PHASE3
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle
NCT03609372 ·Status: WITHDRAWN ·Phase: NA
-
Gardasil Vaccination in Post Stem Cell Transplant Patients
NCT01092195 ·Status: COMPLETED ·Phase: PHASE1
-
Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)
NCT00092495 ·Status: COMPLETED ·Phase: PHASE3
-
GARDASIL Reexamination Study (V501-059)
NCT01062074 ·Status: COMPLETED
-
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
NCT00092547 ·Status: COMPLETED ·Phase: PHASE3
-
HPV IIS Reminder/Recall- New York State
NCT03057379 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
NCT01461993 ·Status: COMPLETED ·Phase: PHASE2
-
Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
NCT00260039 ·Status: COMPLETED ·Phase: PHASE2
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
NCT05668572 ·Status: UNKNOWN ·Phase: PHASE3
-
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania
NCT04953130 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
NCT01047345 ·Status: COMPLETED ·Phase: PHASE3
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
HPV Vaccine Confident Families
NCT06002282 ·Status: SUSPENDED ·Phase: NA
-
HPV Centralized R/R RCT #2 - New York State
NCT03294551 ·Status: COMPLETED ·Phase: NA
-
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)
NCT01914367 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting
NCT01184079 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
NCT01462357 ·Status: COMPLETED ·Phase: PHASE3